Genvor Inc. (GNVR) intrinsic value & 10-year financials
Genvor Inc. (GNVR) has no Graham intrinsic value right now because the formula needs positive earnings.
- Graham intrinsic value
- —
- Share price (Oct 17, 2026)
- $0.68
- Market cap
- $17.5M
- Revenue (FY2025)
- —
- ROIC (10-yr avg)
- 269.6%
- Free cash flow (FY2025)
- —
GNVR 10-year financial history
| Fiscal year | Revenue | Net income | EPS (diluted) | Free cash flow | Operating margin | ROIC |
|---|---|---|---|---|---|---|
| FY2025 | — | -$5.6M | -$0.22 | — | — | 522.4% |
| FY2024 | — | -$2.9M | -$0.15 | — | — | 465.4% |
| FY2023 | — | -$1.7M | -$0.07 | — | — | 278.6% |
| FY2022 | — | — | — | — | — | — |
| FY2021 | $0 | -$3.4M | — | — | — | 275.2% |
| FY2020 | $0 | -$4.9K | — | — | — | 29.3% |
| FY2019 | $0 | -$6.0K | — | — | — | 46.7% |
| FY2018 | — | — | — | — | — | — |
Source: annual 10-K filings on SEC EDGAR. Figures in USD.
Executive summary
Genvor Inc revenue growth over the past decade is N/A; insufficient history prevents a reliable 10-year CAGR calculation.
Genvor Inc has earned high returns on invested capital, averaging 15.2% ROIC over the available history. High ROIC is consistent with a durable franchise, but it is not by itself proof of an economic moat.
Genvor Inc capital allocation metrics are N/A for the decade; share count and net debt history are incomplete.
Benjamin Graham lens
Genvor Inc is evaluated under Benjamin Graham's defensive framework using SEC EDGAR fundamentals using an 8.5 + 2g earnings multiple and a 5.1% AAA bond-yield baseline.